Extramedullary myeloma progressed to plasmablastic myeloma.
作者信息
Xu Ke, Kyriakou Charalampia
机构信息
Haematology University College London Hospitals NHS Foundation Trust.
Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories University College London Hospitals NHS Foundation Trust.
出版信息
Clin Hematol Int. 2024 Jan 12;6(1):13-15. doi: 10.46989/001c.92050. eCollection 2024.
Abstract
摘要
相似文献
1
Extramedullary myeloma progressed to plasmablastic myeloma.髓外骨髓瘤进展为浆母细胞性骨髓瘤。
Clin Hematol Int. 2024 Jan 12;6(1):13-15. doi: 10.46989/001c.92050. eCollection 2024.
2
Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.中国台湾的浆细胞骨髓瘤常表现为骨髓外和结外肿块，类似于浆细胞淋巴瘤。
Virchows Arch. 2022 Aug;481(2):283-293. doi: 10.1007/s00428-022-03342-3. Epub 2022 Jun 3.
3
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.多发性骨髓瘤髓外浆细胞瘤转化的遗传基础。
Am J Surg Pathol. 2020 Jun;44(6):838-848. doi: 10.1097/PAS.0000000000001459.
4
Plasmablastic extramedullary plasmacytoma associated with Epstein-Barr virus arising in an immunocompetent patient with multiple myeloma.与爱泼斯坦-巴尔病毒相关的浆母细胞性髓外浆细胞瘤，发生于一名患有多发性骨髓瘤的免疫功能正常患者。
Intern Med. 2011;50(21):2615-20. doi: 10.2169/internalmedicine.50.4892. Epub 2011 Nov 1.
5
Extra-skeletal plasmablastic myeloma presenting as palatal growth - An unusual entity.表现为腭部肿物的骨外浆母细胞性骨髓瘤——一种罕见的实体
Int J Surg Case Rep. 2017 Nov 20;41:423-426. doi: 10.1016/j.ijscr.2017.11.023. eCollection 2017.
6
Incidental diagnosis of a rare pancreatic plasmacytoma with plasmablastic features.偶然诊断出一例具有浆母细胞特征的罕见胰腺浆细胞瘤。
Proc (Bayl Univ Med Cent). 2022 Oct 19;36(1):85-86. doi: 10.1080/08998280.2022.2132790. eCollection 2023.
7
[Plasmablastic myeloma initially presented with ascites].浆母细胞性骨髓瘤最初表现为腹水。
Rinsho Ketsueki. 2022;63(3):194-200. doi: 10.11406/rinketsu.63.194.
8
Gastrointestinal bleeding as initial presentation of extramedullary plasma cell neoplasms: A case report and review of the literature.胃肠道出血作为髓外浆细胞肿瘤的首发表现：一例病例报告及文献复习
World J Gastrointest Endosc. 2019 Apr 16;11(4):308-321. doi: 10.4253/wjge.v11.i4.308.
9
Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.来那度胺单药诱导缓解治疗初治浆细胞样骨髓瘤1例报告
Clin Lymphoma Myeloma. 2009 Aug;9(4):328-30. doi: 10.3816/CLM.2009.n.065.
10
Aggressive Plasmablastic Myeloma With Extramedullary Cord Compression and Hyperammonemic Encephalopathy: Case Report and Literature Review.伴髓外压迫和高氨血症性脑病的侵袭性浆细胞骨髓瘤：病例报告及文献复习。
Anticancer Res. 2021 Nov;41(11):5839-5845. doi: 10.21873/anticanres.15403.
本文引用的文献
1
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.一项针对BRAFV600E突变型多发性骨髓瘤的BRAF/MEK联合抑制的2期临床试验。
Blood. 2023 Apr 6;141(14):1685-1690. doi: 10.1182/blood.2022017789.
2
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.浆母细胞形态——一个与临床和实验室指标相关的独立预后因素：东部肿瘤协作组（ECOG）骨髓瘤试验E9486，ECOG骨髓瘤实验室组报告
Blood. 1998 Apr 1;91(7):2501-7.
3
Multiple myeloma: significance of plasmablastic subtype in morphological classification.多发性骨髓瘤：浆母细胞亚型在形态学分类中的意义
Blood. 1985 Feb;65(2):305-10.
Zotero 插件